Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 12;7(4):292.
doi: 10.3390/jof7040292.

Triazole-Resistance in Environmental Aspergillus fumigatus in Latin American and African Countries

Affiliations

Triazole-Resistance in Environmental Aspergillus fumigatus in Latin American and African Countries

Agustin Resendiz-Sharpe et al. J Fungi (Basel). .

Abstract

Triazole-resistance has been reported increasingly in Aspergillus fumigatus. An international expert team proposed to avoid triazole monotherapy for the initial treatment of invasive aspergillosis in regions with >10% environmental-resistance, but this prevalence is largely unknown for most American and African countries. Here, we screened 584 environmental samples (soil) from urban and rural locations in Mexico, Paraguay, and Peru in Latin America and Benin and Nigeria in Africa for triazole-resistant A. fumigatus. Samples were screened using triazole-containing agars and confirmed as triazole-resistant by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth dilution reference method. Isolates were further characterized by cyp51A sequencing and short-tandem repeat typing. Fungicide presence in samples was likewise determined. Among A. fumigatus positive samples, triazole-resistance was detected in 6.9% (7/102) of samples in Mexico, 8.3% (3/36) in Paraguay, 9.8% (6/61) in Peru, 2.2% (1/46) in Nigeria, and none in Benin. Cyp51A gene mutations were present in most of the triazole-resistant isolates (88%; 15/17). The environmentally-associated mutations TR34/L98H and TR46/Y121F/T289A were prevalent in Mexico and Peru, and isolates harboring these mutations were closely related. For the first time, triazole-resistant A. fumigatus was found in environmental samples in Mexico, Paraguay, Peru, and Nigeria with a prevalence of 7-10% in the Latin American countries. Our findings emphasize the need to establish triazole-resistance surveillance programs in these countries.

Keywords: Africa; America; Aspergillus fumigatus; antifungal resistance; environment; epidemiology.

PubMed Disclaimer

Conflict of interest statement

K.L. has received consultancy fees from MSD, SMB Laboratories Brussels, and Gilead; travel support from Pfizer and MSD; and speaker fees from Gilead, MSD, FUJIFILM WAKO, and Pfizer. J.M. has received research grants from Merck/MSD, Gilead Sciences, and Pfizer; is a consultant to Astellas, Basilea, Bio-Rad, Merck/MSD, Pfizer, Schering-Plough, F2G, Gilead Sciences, Cidara, Scynexis, Amplyx, and Luminex; and has served on the speaker’s bureau of Astellas, Gilead Sciences, Bio-Rad, Merck/MSD, Pfizer, Schering-Plough, Basilea, and Viropharma/Shire. P.E.V. received research grants from Gilead Sciences, Astellas, MSD, F2G, and Bio-Rad; he is a speaker for Gilead Sciences and MSD; and is on the advisory boards for Pfizer, MundiPharma, Cidara, MSD, and F2G. The remaining authors have nothing to declare.

Figures

Figure 1
Figure 1
Circular phylogenetic tree depicting the relationship among triazole-resistant and susceptible Aspergillus fumigatus isolates. Genetic relationship between triazole-resistant isolates and selected susceptible Aspergillus fumigatus isolates from this study and selected publicly available triazole-resistant and susceptible worldwide isolates (short tandem repeat; Euclidian dissimilarity and Ward’s method for row agglomeration). Isolates were clustered into two clades: clade-I (red sample ID number) and clade-II (black sample ID number). Figures represent isolates country of origin. Color inside figures represent the cyp51A gene sequencing result (mutations) of triazole-resistant isolates. Abbreviations: ID = identification.

Similar articles

Cited by

References

    1. Kosmidis C., Denning D.W. The clinical spectrum of pulmonary aspergillosis. Thorax. 2014;70:270–277. doi: 10.1136/thoraxjnl-2014-206291. - DOI - PubMed
    1. Schauwvlieghe A.F.A.D., Rijnders B.J.A., Philips N., Verwijs R., Vanderbeke L., Van Tienen C., Lagrou K., Verweij P.E., Van De Veerdonk F.L., Gommers D., et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study. Lancet Respir. Med. 2018;6:782–792. doi: 10.1016/S2213-2600(18)30274-1. - DOI - PubMed
    1. Verweij P.E., Gangneux J.-P., Bassetti M., Brüggemann R.J.M., A Cornely O., Koehler P., Lass-Flörl C., van de Veerdonk F.L., Chakrabarti A., Hoenigl M. Diagnosing COVID-19-associated pulmonary aspergillosis. Lancet Microbe. 2020;1:e53–e55. doi: 10.1016/S2666-5247(20)30027-6. - DOI - PMC - PubMed
    1. Patterson T.F., Thompson G.R., Denning D.W., Fishman J.A., Hadley S., Herbrecht R., Kontoyiannis D.P., Marr K.A., Morrison V.A., Nguyen M.H., et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2016;63:e1–e60. doi: 10.1093/cid/ciw326. - DOI - PMC - PubMed
    1. Ullmann A., Aguado J., Arikan-Akdagli S., Denning D., Groll A., Lagrou K., Lass-Flörl C., Lewis R., Munoz P., Verweij P., et al. Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin. Microbiol. Infect. 2018;24:e1–e38. doi: 10.1016/j.cmi.2018.01.002. - DOI - PubMed

LinkOut - more resources